The on-demand logistics service provider, which counts Transmed and Delivery Hero as existing shareholders, is looking to raise $12.9m in its latest round.

The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.

Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.

Mitsui led a $16.8m round for the green energy and clean energy product supplier, investing together with undisclosed existing backers.

The environmental microbiome testing kit maker has collected capital from investors including Western Digital Capital, 3M Ventures and Agfunder in its series A round.

Amazon has led the electric truck developer's latest round, which featured existing backers likely to have included corporates Abdul Latif Jameel and Sumitomo.

Opendoor, whose shareholders include GV and SoftBank Vision Fund, is reportedly seeking $200m at a $3.7bn valuation, which would take its total funding to $1.25bn.

Passage Bio has launched to develop treatments for diseases affecting the central nervous system, after raising almost $116m in a series A round backed by Lilly Asia Ventures.

CK Hutchinson's Longliv fund has made its first investment, leading the medical diagnostic system producer's $27.8m series C round.

OP Corporate Bank has backed a $22.6m round for Nordcloud, which the cloud infrastructure developer will use to hire new staff and grow internationally.